Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer.

[1]  R. Lennox,et al.  PCD13: PATIENT BENEFIT QUESTIONNAIRE (PBQ) FOR XEROSTOMIA: DEVELOPMENT AND VALIDATION REPORT , 1999 .

[2]  M. Ajax,et al.  PCD12: COST OF MANAGING MUCOSITIS AND XEROSTOMIA IN HEAD AND NECK CANCER PATIENTS UNDERGOING CHEMORADIOTHERAPY (CRT) OR RADIATION (RT) , 1999 .

[3]  T. Bodenheimer,et al.  The American health care system--the movement for improved quality in health care. , 1999, The New England journal of medicine.

[4]  D. Brizel,et al.  6 Final report of a phase III randomized trial of amifostine as a radioprotectant in head and neck cancer , 1999 .

[5]  Taylor Murray,et al.  Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.

[6]  J. Dwyer,et al.  Nutritional implications of dental and swallowing issues in head and neck cancer. , 1998, Oncology.

[7]  J. Büntzel,et al.  Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  M. Synodinou,et al.  The prophylactic use of amifostine in the prevention of chemoradiation induced mucositis and xerostomia in head and neck cancer , 1998 .

[9]  D. Brizel,et al.  Randomized phase III trial of radiation±Ethyol® (Amifostine) in patients with head and neck cancer , 1997 .

[10]  A. Laviano,et al.  Nutritional issues in cancer management. , 1996, Nutrition.

[11]  Ganley Bj.  Effective mouth care for head and neck radiation therapy patients. , 1995 .

[12]  S. McDonald,et al.  Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction. , 1994, International journal of radiation oncology, biology, physics.

[13]  J. Rieke,et al.  A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  R. Little.  Pattern-Mixture Models for Multivariate Incomplete Data , 1993 .

[15]  P. Fox,et al.  Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction , 1993, Cancer.

[16]  B. Baum,et al.  How Much Saliva is Enough , 1991 .

[17]  P. Fox,et al.  Subjective reports of xerostomia and objective measures of salivary gland performance. , 1987, Journal of the American Dental Association.

[18]  H. Niibe,et al.  Clinical study of the radioprotective effects of Amifostine (YM-08310, WR-2721) on chronic radiation injury. , 1986, International journal of radiation oncology, biology, physics.

[19]  W. Goodwin,et al.  The value of the prognostic nutritional index in the management of patients with advanced carcinoma of the head and neck. , 1984, Head & neck surgery.

[20]  M. Moore.  The effect of radiation on connective tissue. , 1984, Otolaryngologic clinics of North America.

[21]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.